Aleksey Kazantsev - Concepedia

Author

Aleksey Kazantsev

Also Known As

A. G. Kazantsev, A. YU. KAZANTSEV, Aleksey G Kazantsev, Aleksey G. Kazantsev, Aleksey Kazantsev, Aleksey G. Kazantsev, Aleksey G. Kazantsev

Publications

8.3K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University MaineGeneral Medical Center Massachusetts Institute of Technology University of California, Irvine

About

Aleksey Kazantsev is an author at Massachusetts General Hospital specializing in medicine, neurodegenerative diseases, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	19	3K
2	Natural Sciences	6	6	591
3	Biochemistry	4	4	468
4	Social Sciences	2	2	242
5	Biology	1	1	94

Aleksey Kazantsev

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease Tiago F. Outeiro, Eirene Kontopoulos, Stephen M. Altmann, Science Neurodegenerative DiseasesMitophagyDopaminergic Cell DeathMedicineGenetics	2007	1K
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription Joan S. Steffan, Aleksey Kazantsev, Olivera Spasić-Bošković, Proceedings of the National Academy of Sciences	2000	1K
Role of Mouse Cryptochrome Blue-Light Photoreceptor in Circadian Photoresponses Randy Thresher, Martha Hotz Vitaterna, Yasuhide Miyamoto, Science	1998	405
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis Ruth Luthi‐Carter, David Taylor, Judit Pallos, Proceedings of the National Academy of Sciences	2010	339
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis Erica Rockabrand, Natalia Slepko, A. Pantalone, Human Molecular Genetics	2006	286
Putative Human Blue-Light Photoreceptors hCRY1 and hCRY2 Are Flavoproteins David S. Y. Hsu, Xiaodong Zhao, Shaying Zhao, Biochemistry	1996	285
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases Ruth A. Bodner, Tiago F. Outeiro, Stephen M. Altmann, Proceedings of the National Academy of Sciences Molecular BiologyNeurochemical BiomarkersPharmacological PromotionProtein FoldingChemical Compounds	2006	258
A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration <i>in vivo</i> Xiaoqian Zhang, Donna L. Smith, Anatoli B. Meriin, Proceedings of the National Academy of Sciences	2005	243
The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models Vanita Chopra, Luisa Quinti, Jinho Kim, Cell Reports Neurodegenerative DiseasesMitophagyHuntington ’Brain AtrophyMedicine	2012	214
The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS Michele M. Maxwell, Elizabeth M. Tomkinson, Johnathan Nobles, Human Molecular Genetics Microtubule DeacetylaseMolecular RegulationCytoskeletonSirtuin 2Social Sciences	2011	203

Page 1